Skip to main content

WEBINAR: A Novel Method for Rapidly Assessing Potency of Measles and Rubella Vaccines

January 20, 2021
Dr. Erica Dawson, Chief Technology Officer, InDevR

WEBINAR: A Novel Method for Rapidly Assessing Potency of Measles and Rubella Vaccines
Thursday, January 21, 2021, 5:00 pm CET
Speaker: Dr. Erica Dawson
Title: Chief Technology Officer, InDevR

Registration Link:
https://dcvmn.webex.com/dcvmn/onstage/g.php?MTID=ea90d9c93b3a7b2f67f2ae1719fa54b99

Bio: Dr. Dawson earned her Ph.D. in Analytical Chemistry from The University of North Carolina at Chapel Hill, holds a B.S. from Hartwick College in Oneonta, NY, and completed her postdoctoral training at the University of Colorado at Boulder. Erica has published a wide number of high impact scientific publications and is a named inventor on numerous issued or pending US and worldwide patents. She has been integral in leading the research and development and transfer to manufacturing of InDevR products since 2006.